Adaptimmune Therapeutics
ADAP
#8446
Rank
โ‚น13.14 B
Marketcap
โ‚น51.37
Share price
0.82%
Change (1 day)
23.53%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Net assets

Net assets on the balance sheet as of September 2024 : โ‚น6.79 Billion

According to Adaptimmune Therapeutics's latest financial reports the company has โ‚น6.79 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Adaptimmune Therapeutics - Net assets on balance sheet (from 2014 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚น3.28 B-51.45%
2022-12-31$โ‚น6.77 B-55.8%
2021-12-31$โ‚น15.32 B-38.57%
2020-12-31$โ‚น24.95 B183.04%
2019-12-31$โ‚น8.81 B-48.93%
2018-12-31$โ‚น17.26 B33.19%
2017-12-31$โ‚น12.96 B14.8%
2016-12-31$โ‚น11.29 B
2015-06-30$โ‚น16.50 B11306.88%
2014-06-30$โ‚น0.14 B-212.75%
2013-06-30$-โ‚น0.13 Billion1739.82%
2012-06-30$-โ‚น6.98 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-โ‚น44.71 Billion-758.14%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.76 B-29.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.74 B-30.21%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚น193.24 B 2,744.67%๐Ÿ‡บ๐Ÿ‡ธ USA